4D Molecular Therapeutics Cash Flow Statement (2019-2025) | FDMT

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -13.15M-15.13M-7.81M-20.42M-16.30M-7.59M-22.23M-25.08M-26.29M-28.09M-25.70M-27.38M-28.66M-29.62M-10.10M-32.27M-32.39M-34.91M-43.84M-49.65M-48.04M-54.60M-56.85M
Depreciation and Depletion 0.30M0.40M0.40M0.30M0.40M0.40M0.40M0.40M0.40M0.50M0.50M1.00M1.00M1.10M1.10M1.30M1.20M1.20M1.20M1.20M1.30M1.30M1.30M
Share-based Compensation 1.08M1.04M1.15M1.72M2.33M3.82M3.92M3.73M3.93M4.32M4.52M4.35M4.22M4.97M4.56M5.91M5.97M6.07M6.49M7.58M6.99M4.96M4.52M
Gains from Sales and Divestitures 0.01M0.02M0.03M0.05M0.02M0.07M0.11M
Gains from Investment Securities 2.47M-0.02M0.00M-0.06M3.96M-0.48M0.48M5.02M6.04M-0.44M6.59M-0.11M0.07M3.43M0.09M1.55M9.95M10.66M2.35M-0.01M
Non-cash Items 19.97M97.11M1.36M1.36M1.38M24.67M1.70M2.01M2.28M48.05M2.61M2.94M3.15M46.86M3.32M3.73M4.14M4.54M4.97M5.49M6.02M
Cash from Operations -13.87M-6.17M-13.37M-17.50M-15.37M-16.20M-15.72M-21.84M-23.55M-19.90M-21.02M-22.21M-27.91M-22.07M-1.17M-24.65M-29.09M-30.24M-29.39M-45.86M-47.76M-43.38M-46.50M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.36M0.37M0.38M0.38M-0.58M-0.47M-0.24M2.77M0.40M0.34M0.40M0.41M0.76M2.33M2.24M1.85M1.27M1.17M1.15M
Depreciation & Amortization (CF) 0.34M0.36M0.37M0.37M0.38M0.37M0.38M0.39M0.41M0.47M0.52M1.01M1.03M1.08M0.99M1.10M1.17M1.19M1.19M1.10M1.05M1.17M1.26M
Change in Working Capital
Change in Receivables -0.10M-0.15M0.17M0.59M-0.52M0.25M-0.43M-0.74M-0.05M
Change in Account Payables -0.33M2.58M-2.77M0.57M-0.60M0.43M0.80M1.66M-1.68M0.23M-1.70M1.51M-0.33M0.95M1.37M-1.09M0.70M-0.79M-0.51M1.46M-0.23M4.55M-1.84M
Change in Accured Expenses 0.61M3.41M-2.15M0.03M-1.45M0.55M1.06M0.54M-1.07M0.65M1.08M1.82M-3.40M1.16M3.61M2.00M-2.39M3.17M8.11M-2.37M-2.31M3.11M4.98M
Investing Activities
Capital Expenditures 0.72M0.12M-0.33M0.49M0.64M0.74M2.63M5.10M6.41M2.07M1.96M1.09M1.01M0.81M0.41M0.55M0.71M0.35M1.78M0.95M0.63M0.07M-0.09M
Change in Acquisitions & Divestments 5.00M12.00M65.72M205.28M-135.19M58.87M55.52M30.39M28.51M14.78M23.57M64.87M65.79M166.66M101.62M32.93M
Cash from Investing Activities -0.72M-0.12M0.35M-0.51M-0.64M-0.74M-139.01M-32.29M-54.11M57.47M15.37M-35.78M43.13M49.29M29.98M-6.68M-263.26M-73.54M27.30M7.06M31.95M-13.85M17.78M
Financing Activities
Other financing activities 0.39M-0.03M-0.35M0.95M-0.95M0.25M0.11M-0.36M0.47M0.07M0.26M
Change in Capital Stock
Shares Issued 0.01M204.70M0.10M114.30M0.88M-0.88M1.42M128.30M-0.51M34.90M281.25M0.00M-300.85M
Misc.
Cash from Financing Activities -0.39M72.49M0.90M205.98M-0.85M0.82M1.98M116.14M0.63M-0.05M0.46M2.05M10.99M130.52M10.56M4.76M318.83M17.25M0.57M0.60M0.12M
Change in Cash -14.98M66.20M-12.12M187.97M-16.86M-16.12M-152.75M62.01M-77.03M37.51M-5.19M-55.95M26.22M157.74M39.37M-26.57M26.49M-86.53M-1.52M-38.20M-15.81M-56.37M-28.60M
Beginning Cash Balance 49.65M14.98M-66.20M12.12M88.75M276.73M259.87M243.74M90.99M153.00M75.97M113.48M108.30M52.35M78.57M236.31M275.68M249.11M275.59M189.06M187.54M149.34M133.53M77.16M
Free Cash Flow -14.59M-6.29M-13.04M-17.99M-16.01M-16.94M-18.36M-26.93M-29.96M-21.97M-22.98M-23.31M-28.92M-22.87M-1.58M-25.20M-29.80M-30.59M-31.17M-46.81M-48.39M-43.44M-46.41M
Net Cash Flow -14.98M66.20M-12.12M187.97M-16.86M-16.12M-152.75M62.01M-77.03M37.51M-5.19M-55.95M26.22M157.74M39.37M-26.57M26.49M-86.53M-1.52M-38.20M-15.81M-57.23M-28.60M